Foresite Capital Management V, LLC Kinnate Biopharma Inc. Transaction History

Foresite Capital Management V, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	BUY	$2.33 - $6.84 $3.61 Million - $10.6 Million	1,550,956 Added 78.53%	3,525,957 $10.7 Million
Q1 2023 May 12, 2023	BUY	$3.46 - $7.98 $3.81 Million - $8.78 Million	1,100,000 Added 125.71%	1,975,001 $12.3 Million
Q4 2020 Feb 16, 2021	BUY	$36.35 - $45.25 $31.8 Million - $39.6 Million	875,001 New	875,001 $34.8 Million

292K

Ticker KNTE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 44,145,600
Description
Kinnate Biopharma Inc., a biopharmaceutical company, focuses on the discovery and development of small molecule kinase inhibitors to treat genomically defined cancers in the United States. The company develops KIN-2787, a rapidly accelerated fibrosarcoma inhibitor for the treatment of patients with lung cancer, melanoma, and other solid tumors; ...

Get notified when there are updates to the investment portfolio of Foresite Capital Management V, LLC, based on Form 13F filings with the SEC.

Stay updated on Foresite Capital Management V, LLC with notifications on news.